Mumbai, Maharashtra, India, October 2025 — Cipla Limited (BSE: 500087; NSE: CIPLA EQ) announced that it has elevated Achin Gupta, Global Chief Operating Officer (GCOO), to Managing Director & Global Chief Executive Officer (MD & GCEO) effective April 1, 2026, for a term of five years. The appointment will be proposed to the shareholders for approval. Achin will serve as MD & GCEO Designate beginning January 1, 2026, succeeding Umang Vohra, who has led Cipla as MD & GCEO since 2016. This leadership transition is part of a structured succession process developed by the Board and Umang, ensuring continuity, stability, and a clear vision for the future.
Achin Gupta has been serving as GCOO since February 2025, overseeing Commercial Markets, API, Manufacturing, and Supply Chain. He joined Cipla in 2021 as CEO of the One India Business, becoming an integral member of the Management Council. Achin has been pivotal in driving strong growth, expanding Cipla’s reach in chronic therapies and underserved geographies, and fortifying its operational backbone. Under his leadership, the India Business achieved market-leading profitability, modernized its retail force, and introduced consumer-focused innovations. He also spearheaded strategic global partnerships, positioning Cipla as a preferred innovation-led collaborator.
An alumnus of IIT Delhi (MTech, Biochemical Engineering & Biotechnology) and IIM Ahmedabad (MBA), Achin brings over two decades of leadership experience and a strong track record as an entrepreneurial leader, fostering a culture of purpose, innovation, and accountability.
Umang Vohra, who joined Cipla in 2015 as Global Chief Financial & Strategy Officer and took over as MD & GCEO in 2016, has led the company through a decade of transformation guided by the purpose of “Caring for Life.” His leadership has been instrumental in strengthening Cipla’s global lung leadership, antimicrobial resistance stewardship, and digital and manufacturing capabilities, while investing in next-generation therapies. Under his stewardship, Cipla consistently achieved top rankings across key geographies, while embedding sustainability, good governance, and a strong employee value proposition at its core.
Dr. Y.K. Hamied, Chairman, Cipla Limited, said:
“I thank Umang for his stewardship over the last ten years, his outstanding contributions and dedication to Cipla’s purpose of Caring for Life and combining business with a humanitarian approach. We wish Umang continued success in his future career. We are pleased to welcome Achin Gupta as he steps into this role, and I am confident he will lead Cipla to its next phase of progress and growth.”
Umang Vohra, Current MD & GCEO, stated:
“My ten years at Cipla have been filled with immense pride in what we’ve built together. Guided by our purpose of Caring for Life, I have had the privilege of working with passionate teams who consistently put patients first and drive innovation across the business. I’m deeply grateful to our Chairman, Dr. Y K Hamied, and the Board for their trust and support throughout this journey. As I prepare to hand over the reins, I’m confident that Achin Gupta will lead Cipla forward with vision and purpose.”
Achin Gupta, MD & GCEO Designate, said:
“It is an honour to be entrusted with the responsibility of leading Cipla as its next MD & GCEO. Cipla’s legacy of purpose-driven innovation and patient-centric care is deeply inspiring, and I am committed to building on the strong foundation laid by Umang and the leadership team. As we move forward, my focus will remain on driving sustainable growth, deepening our impact across markets, and continuing to innovate with purpose.”
About Cipla
Founded in 1935, Cipla Limited is a global leader in pharmaceuticals, known for its compassionate approach to healthcare, commitment to sustainability, and focus on affordability and accessibility. Operating in 80+ countries with a portfolio of over 1,500 products across various therapeutic areas, Cipla continues to pioneer innovative, life-saving treatments while staying true to its mission of “Caring for Life.”
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
